15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Ternium SA ADR, 1 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $40.00 to $45.00, so the covering firms are broadly aligned. The average target of $41.63 sits 16% below the current $49.29. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 1 to 0 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.75 next quarter toward $6.60 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy125%
Hold375%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Ternium SA ADR.
As of Jul, 1 of 4 firms rate TX a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
TX EPS & revenue forecast
EPS · NEXT QUARTER
$1.75
Range $1.52 – $1.98 · 3 analysts · +650% YoY
Next period, 3 analysts expect Ternium SA ADR to earn $1.75 a share (range $1.52 – $1.98), versus $0.23 a year earlier. Full-year consensus is $5.89, growing to $6.60 the year after.
REVENUE · NEXT QUARTER
$4.6B
Range $4.4B – $4.7B · 3 analysts · +15% YoY
Revenue is expected to reach $4.6B (range $4.4B – $4.7B), +15.4% year-over-year. Full-year consensus is $17.3B, rising to $18.1B next year.
Top analysts covering Ternium SA ADR
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on TX.
#1
Timna Tanners
Wells Fargo
Hold
$45.00-8.7% to target
Coverage
—
+ Follow
#2
AS
Alfonso Salazar
Scotiabank
Hold
$40.00-18.8% to target
Coverage
—
+ Follow
#3
CG
Caio Greiner
UBS
Hold
$41.00-16.8% to target
Coverage
—
+ Follow
#4
RA
Rodolfo Angele
JP Morgan
Buy
$44.50-9.7% to target
Coverage
—
+ Follow
#5
CD
Carlos De Alba
Morgan Stanley
Hold
$34.00-31.0% to target
Coverage
—
+ Follow
TX stock forecast FAQ
What is TX's average 12-month price target?+
The 4 analysts with a live target average $41.63 for Ternium SA ADR over the next 12 months, ranging from a $45.00 high to a $40.00 low.
Is TX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 1 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for TX?+
The Street-high target is $45.00 (Wells Fargo), and the Street-low is $40.00 (Scotiabank). The average of all 4 active targets is $41.63.
How many Wall Street analysts cover TX?+
4 analysts have an active rating on Ternium SA ADR, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering TX?+
Among analysts who currently cover TX, Timna Tanners of Wells Fargo has the strongest overall Quantellect track record. Their current call is Hold with a $45.00 target.
What is Ternium SA ADR's projected EPS for next quarter?+
The consensus estimate is $1.75 per share (range $1.52 – $1.98) across 3 analysts. Full-year EPS is projected at $5.89, rising to $6.60 the following year.
How much revenue is Ternium SA ADR expected to report next quarter?+
Consensus revenue is $4.6B (range $4.4B – $4.7B). Full-year revenue is projected at $17.3B, growing to $18.1B next year.
Have analysts been upgrading or downgrading TX lately?+
As of Jul, 1 of 4 firms rate TX a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their TX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
